[Diabetes-Talk] Dexcom 'very confident' about G7 CGM's upcoming FDA approval

[Patricia Maddix]

It certainly would be nice if the price of Dexcom would come down. For many many years I did have to pay out-of-pocket for sensors as I started using them with Medtronic in 2006. Eventually insurance recognized them as a item that they really needed to cover but was slow in coming.  Historically it’s interesting that my previous commercial insurance through an employer covered the Medtronic sensors for a number of years but Medicare does not.  I think I read somewhere that the new Medtronic sensors coming out will be covered by Medicare because they will be approved to make treatment decisions without requiring fingersticks. This apparently was the hangup.
Patricia

Sent from my iPhone

> On Oct 29, 2022, at 2:24 PM, gary-melconian <gmelconian619 at gmail.com> wrote:
> 
> That is good but lets se them lower the price of the dexcom g7 series. As abbot with libre 3 will be taking a big chunck of market share from them with the type 2 market as they have done in the past few years with libre 1 and libre 2 an libre 3 with it being real time  will probably even take more chuncks of the type 2 mmarket place as an affordable real time  cgm solution.  Where  dexcom has not had great success.  So I am curious if there  will be an affordable dexcom for those  who are not covered by insurance or have lost  their insurance due to the past few years of the pandemic .  
>